Navigation Links
KGI Offers Mammalian Cell Culture Program for Biotech Industry Professionals
Date:9/18/2008

CLAREMONT, Calif., Sept. 18 /PRNewswire/ -- Keck Graduate Institute (KGI) today announced that it will conduct a five-day program for industry professionals to learn the latest developments in mammalian cell culture, from November 2-7, 2008.

"Mammalian cell biotechnology has undergone explosive growth over the last 25 years," said Matt Croughan, PhD, the George B. and Joy Rathmann Professor and director of the Amgen Bioprocessing Center at KGI. "There is strong demand for individuals skilled in mammalian cell biotechnology, and this new program will allow those in industry the opportunity to become more knowledgeable, operationally adept and business savvy about this growing field."

According to Croughan, recombinant Chinese hamster ovary (CHO) cells now surpass E Coli and all other expression systems for recombinant protein production, with total annual sales exceeding $30 billion. Amgen and Genentech make many of their products, including Enbrel(R) (arthritis), Aranesp(R) (kidney disease, anemia), Herceptin(R) (breast cancer) and Rituxan(R) (non-Hodgkin's lymphoma), from CHO cells.

The primary goal of the course is to provide an advanced background in mammalian cell biotechnology. The scientific, engineering and practical industrial aspects will be presented in a series of lectures and laboratory exercises held in the Amgen Bioprocessing Center at KGI. The lectures will cover a broad range of issues, from cell line engineering and design of culture medium to control of cell metabolism and operation of high density fed-batch cultures in large-scale bioreactors. In keeping with KGI's hands-on learning philosophy, the laboratory exercises will provide experience with many of the techniques and principles taught in that day's lectures. Course attendees will gain first-hand experience in setting up, running and analyzing data from high-density, fed-batch cultures in lab scale Applikon bioreactors.

Croughan was employed at Genentech from 1988 to 1998. In the early 1990s, he led the development of the first FDA-licensed, fed-batch CHO cell culture process, a breakthrough platform technology now used throughout the biopharmaceutical industry. Over the last 10 years, he has consulted with over 40 firms in biopharmaceutical manufacturing and process development, on products ranging from monoclonal antibodies to vaccines, gene therapy vectors and stem cells.

KGI Background

Educating the future leaders of the bioscience industry, Keck Graduate Institute (KGI) offers an interdisciplinary graduate education through its Master of Bioscience (MBS) degree program and its PhD program in Applied Life Sciences. Using team-based learning and real-world projects, KGI's innovative curriculum seamlessly combines applied life sciences, bioengineering, bioethics and business management. KGI also has a robust research program concentrating on the translation of basic discoveries in the life sciences into applications that can benefit society. KGI is a member of The Claremont Colleges, located in Claremont, California.

Keck Graduate Institute of Applied Life Sciences is dedicated to education and research aimed at translating into practice, for the benefit of society, the power and potential of the life sciences.


'/>"/>
SOURCE Keck Graduate Institute
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ProSource 2.0 Offers Value, Savings for Lab Supplies
2. Friends of the Earth Report on Biofuel Production Offers Incomplete, Outdated and Inaccurate Picture, According to Brazilian Sugarcane Industry Association
3. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
4. GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)
5. Spherics, Inc. Offers Once Daily Extended Release Formulation for Sustained and Stable Pramipexole Delivery
6. Minnesota Chiropractic Association Offers Backpack Safety Checklist
7. BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts
8. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
9. REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008
10. Facelift for Resumes Offers Hope for Job Seekers, says Resume Writing Service
11. Online Career Tool Offers Live Expert Advice Component
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Biotheranostics today ... the role of the Breast Cancer Index (BCI) ... breast cancer are most at-risk for disease recurrence ... include results from three studies advancing the understanding ... related to tumor biology and inform decisions related ...
(Date:12/8/2016)... , December 8, 2016 ... Unternehmen für Molekulargenetik, erweitert seine Palette an anpassbaren ... NGS Custom FH Panels, das ein schnelles und ... ermöglicht. Das Panel bietet eine Erkennung von Einzel-Nukleotid-Variationen ... (CNV) mit einem einzigen kleinen Panel und ermöglicht ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... the World Technology Awards. uBiome is one of just six company finalists in ... , In addition to uBiome, companies nominated as finalists in this year’s awards ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016 ... augmentation remediation technologies and selected NewTechBio,s NT-MAX ... a microbial based beneficial bacteria, in conjunction with ... to correct deficiencies with National Pollutant Discharge Elimination ... 281-8H has experienced a steady history of elevated ...
Breaking Biology Technology:
(Date:12/6/2016)... 6, 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... offering of €500.0 million principal amount of its 1.414% senior ... its 2.425% senior unsecured notes due 2026. ... December 13, 2016, subject to the satisfaction of customary closing conditions.  ... The Company intends to use the ...
(Date:12/2/2016)... 1, 2016 The report "Biometric ... Future Technology (Iris Recognition System), Vehicle Type (Passenger ... Forecast to 2021", published by MarketsandMarkets, the market ... 2016, and is projected to grow to USD ... 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/29/2016)... Nov. 29, 2016 BioDirection, a privately held ... for the objective detection of concussion and other traumatic ... successfully completed a meeting with the U.S. Food and ... test Pre-Submission Package. During the meeting company representatives reviewed ... a precursor to commencement of a planned pilot trial. ...
Breaking Biology News(10 mins):